Cases & Deals

  • Home
  • Practices
  • Biobest receives capital increase from Sofina and some private investors

Share

Biobest receives capital increase from Sofina and some private investors

February 2023

Client(s) Biobest Group NV

Jones Day advised Biobest Group NV in its capital increase in an amount of €98.5 million with cancellation of preferential subscription rights, subscribed by Sofina SA and by other private investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.